Which metabolic abnormality is the most common cause of recurrent calcium oxalate stone formation?

Explanation

## Metabolic Causes of Calcium Oxalate Stone Recurrence **Key Point:** Hypercalciuria (elevated urinary calcium excretion >250 mg/day in women, >300 mg/day in men) is the single most common metabolic abnormality predisposing to recurrent calcium oxalate stone formation. ### Metabolic Risk Factors for Calcium Oxalate Stones | Metabolic Factor | Prevalence in Stone Formers | Mechanism | Clinical Significance | |---|---|---|---| | Hypercalciuria | 40–50% | Increased urinary Ca²⁺ saturation | Most common; multiple etiologies | | Hyperoxaluria | 20–25% | Increased urinary oxalate excretion | Primary (genetic) or secondary (dietary, GI disease) | | Hypocitraturia | 20–30% | Reduced urinary citrate (natural inhibitor) | Often coexists with hypercalciuria | | Hyperuricosuria | 15–20% | Increased urinary uric acid | Promotes heterogeneous nucleation of CaOx | ### Causes of Hypercalciuria 1. **Absorptive hypercalciuria** (most common subtype) - Increased intestinal calcium absorption - Primary defect in gut calcium handling 2. **Renal hypercalciuria** - Impaired renal tubular reabsorption of calcium - Seen in renal tubular acidosis 3. **Resorptive hypercalciuria** - Increased bone resorption (hyperparathyroidism, hyperthyroidism, immobilization) **High-Yield:** Hypercalciuria is present in 40–50% of patients with recurrent calcium oxalate stones, making it the most frequent metabolic abnormality. It is the primary target for dietary and pharmacological intervention. **Mnemonic:** **CHAMP** — Calcium, Hyperparathyroidism, Absorptive, Metabolic, Primary **Clinical Pearl:** Hypocitraturia often coexists with hypercalciuria and amplifies stone risk because citrate is a potent inhibitor of calcium oxalate crystallization. Citrate supplementation is a key preventive strategy. ## Stone Formation Pathophysiology ```mermaid flowchart TD A[Hypercalciuria]:::action --> B[Increased urinary Ca²⁺ concentration] B --> C[Increased saturation of CaOx] C --> D[Heterogeneous nucleation] D --> E[Crystal growth and aggregation] E --> F[Stone formation]:::outcome G[Hyperoxaluria]:::action --> C H[Hypocitraturia]:::action --> C I[Low urine volume/Dehydration]:::action --> C ``` ## Why Other Options Are Less Common as Primary Cause - **Hyperoxaluria (20–25%):** Second most common but less frequent than hypercalciuria. Primary hyperoxaluria is rare (genetic); secondary hyperoxaluria (dietary, inflammatory bowel disease) is more common but still less prevalent overall. - **Hypocitraturia (20–30%):** Frequently coexists with hypercalciuria but is rarely the sole abnormality. Citrate is an inhibitor, so low levels promote stones but do not directly increase saturation like calcium does. - **Hyperuricosuria (15–20%):** Present in minority of stone formers. Acts as a promoter of heterogeneous nucleation rather than a primary driver of saturation.